Compare JFrog Ltd. Ordinary Shares (FROG) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JFrog Ltd. Ordinary Shares vs Inovio Pharmaceuticals Inc — how do they compare? JFrog Ltd. Ordinary Shares trades at $97.61 (market cap $12.10B), while Inovio Pharmaceuticals Inc trades at $1.11 (market cap $119.42M). The key difference: JFrog Ltd. Ordinary Shares is far larger — about 101.3× Inovio Pharmaceuticals Inc's market cap, and JFrog Ltd. Ordinary Shares is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JFrog Ltd. Ordinary Shares for 0 Days and Inovio Pharmaceuticals Inc for 43 Days on average.
| FROG | INO | |
|---|---|---|
Market Cap | $12.10B | $119.42M |
Volume | 773,694 | 2,789,649 |
Sector | Technology | Health |
52-Week High | $104.03 | $2.65 |
52-Week Low | $34.75 | $0.66 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $11.29B | $90.75M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
INO trades at $1.09, down 3.54% on the day, with a bearish technical signal driven by moving averages. The company reported a net loss of $84.95 million in 2025 on minimal revenue of $65,340, with negative profitability metrics, but has beaten EPS estimates in recent quarters. Key near-term catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107.
The investment case hinges on regulatory approval of INO-3107, with a consensus price target of $2.75 implying significant upside. However, extreme financial losses, high cash burn, and dependence on dilutive financing pose substantial risks. Analyst sentiment is cautiously optimistic but reflects high uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JFrog Ltd. Ordinary Shares
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
